Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

EFTUD2 is a novel innate immune regulator restricting hepatitis C virus infection through the RIG-I/MDA5 pathway.

Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, Chung RT.

J Virol. 2015 Apr 15. pii: JVI.00364-15. [Epub ahead of print]

PMID:
25878102
2.

The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.

Lin W, Zhu C, Hong J, Zhao L, Jilg N, Fusco DN, Schaefer EA, Brisac C, Liu X, Peng LF, Xu Q, Chung RT.

J Hepatol. 2014 Dec 3. pii: S0168-8278(14)00887-3. doi: 10.1016/j.jhep.2014.11.038. [Epub ahead of print]

PMID:
25481564
3.

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.

Jilg N, Lin W, Hong J, Schaefer EA, Wolski D, Meixong J, Goto K, Brisac C, Chusri P, Fusco DN, Chevaliez S, Luther J, Kumthip K, Urban TJ, Peng LF, Lauer GM, Chung RT.

Hepatology. 2014 Apr;59(4):1250-61. doi: 10.1002/hep.26653. Epub 2014 Feb 14.

4.

The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.

Goto K, Lin W, Zhang L, Jilg N, Shao RX, Schaefer EA, Zhao H, Fusco DN, Peng LF, Kato N, Chung RT.

J Hepatol. 2013 Nov;59(5):942-8. doi: 10.1016/j.jhep.2013.06.025. Epub 2013 Jul 2.

5.

Transcatheter device closure of a congenital aortic-left atrial tunnel.

Sun HY, Buccola KJ, Punn R, Silverman NH, Peng LF, Perry SB, Balasubramanian S.

Congenit Heart Dis. 2014 Jan-Feb;9(1):E23-6. doi: 10.1111/chd.12059. Epub 2013 Apr 22.

PMID:
23601836
6.

A TALEN genome-editing system for generating human stem cell-based disease models.

Ding Q, Lee YK, Schaefer EA, Peters DT, Veres A, Kim K, Kuperwasser N, Motola DL, Meissner TB, Hendriks WT, Trevisan M, Gupta RM, Moisan A, Banks E, Friesen M, Schinzel RT, Xia F, Tang A, Xia Y, Figueroa E, Wann A, Ahfeldt T, Daheron L, Zhang F, Rubin LL, Peng LF, Chung RT, Musunuru K, Cowan CA.

Cell Stem Cell. 2013 Feb 7;12(2):238-51. doi: 10.1016/j.stem.2012.11.011. Epub 2012 Dec 13.

7.

SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.

Shao RX, Zhang L, Hong Z, Goto K, Cheng D, Chen WC, Jilg N, Kumthip K, Fusco DN, Peng LF, Chung RT.

Antiviral Res. 2013 Feb;97(2):101-7. doi: 10.1016/j.antiviral.2012.12.001. Epub 2012 Dec 10.

8.

Evaluation of pediatric near-infrared cerebral oximeter for cardiac disease.

Kreeger RN, Ramamoorthy C, Nicolson SC, Ames WA, Hirsch R, Peng LF, Glatz AC, Hill KD, Hoffman J, Tomasson J, Kurth CD.

Ann Thorac Surg. 2012 Nov;94(5):1527-33. doi: 10.1016/j.athoracsur.2012.05.096. Epub 2012 Aug 2.

PMID:
22858270
9.

Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.

Kumthip K, Chusri P, Jilg N, Zhao L, Fusco DN, Zhao H, Goto K, Cheng D, Schaefer EA, Zhang L, Pantip C, Thongsawat S, O'Brien A, Peng LF, Maneekarn N, Chung RT, Lin W.

J Virol. 2012 Aug;86(16):8581-91. doi: 10.1128/JVI.00533-12. Epub 2012 Jun 6.

10.

Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.

Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, Chung RT, Yang PL.

J Am Chem Soc. 2012 Apr 25;134(16):6896-9. doi: 10.1021/ja207391q. Epub 2012 Apr 11.

11.

Outcomes after stent implantation for the treatment of congenital and postoperative pulmonary vein stenosis in children.

Balasubramanian S, Marshall AC, Gauvreau K, Peng LF, Nugent AW, Lock JE, McElhinney DB.

Circ Cardiovasc Interv. 2012 Feb 1;5(1):109-17. doi: 10.1161/CIRCINTERVENTIONS.111.964189. Epub 2012 Jan 17.

12.

Hypoplastic left heart syndrome: current considerations and expectations.

Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT, Pahl E, Villafañe J, Bhatt AB, Peng LF, Johnson BA, Marsden AL, Daniels CJ, Rudd NA, Caldarone CA, Mussatto KA, Morales DL, Ivy DD, Gaynor JW, Tweddell JS, Deal BJ, Furck AK, Rosenthal GL, Ohye RG, Ghanayem NS, Cheatham JP, Tworetzky W, Martin GR.

J Am Coll Cardiol. 2012 Jan 3;59(1 Suppl):S1-42. doi: 10.1016/j.jacc.2011.09.022. Review. Erratum in: J Am Coll Cardiol. 2012 Jan 31;59(5):544.

13.

Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.

Fu WJ, Li BL, Wang SB, Chen ML, Deng RT, Ye CQ, Liu L, Fang AJ, Xiong SL, Wen S, Tang HH, Chen ZX, Huang ZH, Peng LF, Zheng L, Wang Q.

Diabetes Res Clin Pract. 2012 Jan;95(1):105-9. doi: 10.1016/j.diabres.2011.09.031. Epub 2011 Oct 20.

PMID:
22015481
14.

A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.

Zhao H, Lin W, Kumthip K, Cheng D, Fusco DN, Hofmann O, Jilg N, Tai AW, Goto K, Zhang L, Hide W, Jang JY, Peng LF, Chung RT.

J Hepatol. 2012 Feb;56(2):326-33. doi: 10.1016/j.jhep.2011.07.026. Epub 2011 Aug 31.

15.

Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase.

Peng LF, Schaefer EA, Maloof N, Skaff A, Berical A, Belon CA, Heck JA, Lin W, Frick DN, Allen TM, Miziorko HM, Schreiber SL, Chung RT.

J Infect Dis. 2011 Aug 15;204(4):609-16. doi: 10.1093/infdis/jir303.

16.

[Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].

Fu WJ, Zheng L, Wang Q, Deng RT, Ye CQ, Wang SB, Peng LF, Xiong SL, Tang HH.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):878-81. Chinese.

17.

Sensitive chemiluminescence immunoassay by capillary electrophoresis with gold nanoparticles.

Liu YM, Mei L, Liu LJ, Peng LF, Chen YH, Ren SW.

Anal Chem. 2011 Feb 1;83(3):1137-43. doi: 10.1021/ac103166n. Epub 2011 Jan 10.

PMID:
21218847
18.

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RT.

J Hepatol. 2011 Aug;55(2):289-98. doi: 10.1016/j.jhep.2010.11.019. Epub 2010 Dec 13.

19.

HIV infection increases HCV-induced hepatocyte apoptosis.

Jang JY, Shao RX, Lin W, Weinberg E, Chung WJ, Tsai WL, Zhao H, Goto K, Zhang L, Mendez-Navarro J, Jilg N, Peng LF, Brockman MA, Chung RT.

J Hepatol. 2011 Apr;54(4):612-20. doi: 10.1016/j.jhep.2010.07.042. Epub 2010 Sep 29.

20.

HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.

Lin W, Wu G, Li S, Weinberg EM, Kumthip K, Peng LF, Méndez-Navarro J, Chen WC, Jilg N, Zhao H, Goto K, Zhang L, Brockman MA, Schuppan D, Chung RT.

J Biol Chem. 2011 Jan 28;286(4):2665-74. doi: 10.1074/jbc.M110.168286. Epub 2010 Nov 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk